Betta Pharmaceuticals Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002DD9
CNY
51.44
-1.52 (-2.87%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,596.40
2,883.98
2,448.25
2,359.10
2,230.67
1,866.80
1,537.04
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,596.40
2,883.98
2,448.25
2,359.10
2,230.67
1,866.80
1,537.04
Raw Material Cost
1,035.42
711.68
565.61
422.44
285.86
243.49
210.88
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
77.67
46.95
56.54
196.00
15.99
39.97
48.93
Selling and Distribution Expenses
1,523.03
1,233.66
1,007.34
1,121.22
1,056.19
857.60
723.30
Other Expenses
39.15
40.45
53.49
46.14
51.63
30.07
26.23
Total Expenditure (Excl Depreciation)
3,027.66
2,396.80
2,164.35
2,201.08
1,874.29
1,441.79
1,245.37
Operating Profit (PBDIT) excl Other Income
568.6999999999999
487.2
283.9
158
356.4
425
291.70000000000005
Other Income
31.42
31.10
117.96
155.35
57.26
302.21
29.88
Operating Profit (PBDIT)
1,122.13
879.14
701.02
567.08
588.10
879.84
466.01
Interest
77.67
46.95
56.54
196.00
15.99
39.97
48.93
Exceptional Items
-58.68
-53.77
-4.93
-8.68
-7.22
-16.98
-6.37
Gross Profit (PBDT)
2,560.98
2,172.30
1,882.64
1,936.66
1,944.80
1,623.30
1,326.16
Depreciation
550.76
371.97
303.49
253.70
174.46
155.86
143.46
Profit Before Tax
435.01
406.46
336.06
108.70
390.43
667.03
267.25
Tax
128.15
7.18
-11.54
-37.19
10.37
65.58
40.62
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
305.33
402.57
348.03
145.42
383.07
606.36
230.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
305.33
402.57
348.03
145.42
383.07
606.36
230.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-19.12
-15.59
-14.42
-20.66
-3.51
-5.27
-4.98
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
286.21
386.98
333.62
124.76
379.56
601.09
225.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,595.16
5,573.81
5,251.08
4,849.06
4,560.89
4,140.78
2,460.54
Earnings per share (EPS)
0.73
0.96
0.83
0.35
0.92
1.49
0.57
Diluted Earnings per share
0.73
0.96
0.83
0.35
0.92
1.49
0.57
Operating Profit Margin (Excl OI)
15.01%
16.51%
11.42%
6.7%
15.98%
22.59%
19.04%
Gross Profit Margin
27.41%
26.99%
26.12%
15.36%
25.32%
44.08%
26.72%
PAT Margin
8.49%
13.96%
14.22%
6.16%
17.17%
32.48%
15.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 24.70% vs 17.80% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -26.05% vs 16.01% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 28.62% vs 45.43% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 65.67% vs -16.99% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Betta Pharmaceuticals Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
3,596.40
0
3,596.40
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,596.40
0
3,596.40
Raw Material Cost
1,035.42
0
1,035.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
77.67
0
77.67
Selling and Distribution Expenses
1,523.03
0
1,523.03
Other Expenses
39.15
0.00
39.15
Total Expenditure (Excl Depreciation)
3,027.66
0
3,027.66
Operating Profit (PBDIT) excl Other Income
568.74
0.00
568.74
Other Income
31.42
0
31.42
Operating Profit (PBDIT)
1,122.13
0
1,122.13
Interest
77.67
0
77.67
Exceptional Items
-58.68
0
-58.68
Gross Profit (PBDT)
2,560.98
0
2,560.98
Depreciation
550.76
0
550.76
Profit Before Tax
435.01
0
435.01
Tax
128.15
0
128.15
Provisions and contingencies
0
0
0.00
Profit After Tax
305.33
0
305.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
305.33
0
305.33
Share in Profit of Associates
0
0
0.00
Minority Interest
-19.12
0
-19.12
Other related items
0.00
0.00
0.00
Consolidated Net Profit
286.21
0
286.21
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,595.16
0
6,595.16
Earnings per share (EPS)
0.73
0
0.73
Diluted Earnings per share
0.73
0
0.73
Operating Profit Margin (Excl OI)
15.01%
0%
0.00
15.01%
Gross Profit Margin
27.41%
0%
0.00
27.41%
PAT Margin
8.49%
0%
0.00
8.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 359.64 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 24.70% vs 17.80% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 28.62 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -26.05% vs 16.01% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 109.07 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 28.62% vs 45.43% in Dec 2024

Annual - Interest
Interest 7.77 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 65.67% vs -16.99% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 15.01%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024